Literature DB >> 30884962

Adapted MMSE and TYM cognitive tests: how much powerful in screening for Alzheimer's disease in Iranian people.

M Salami1, A Alinaghipour2, R Daneshvar3, G A Hamidi1, A Agahi1, M Soheili1, H Akbari4, S M Esmaeili Taba5.   

Abstract

Alzheimer's disease (AD) is a major global health priority and providing an efficient way for early diagnosis of people developing dementia is important. The Mini-Mental State Examination (MMSE, total score = 30) and Test Your Memory (TYM, total score = 50) are widely used as screening tests for cognitive function. In the present study 174 subjects including healthy people (CON group) and those having Alzheimer's disease (AD group) were introduced to MMSE and TYM cognitive tests adjusted to Iranian population. Sensitivities and specificities with optimal cut-off scores, area under curve (AUC), positive predictive value (PPV) and negative predictive value (NPV) were measured for both tests. The MMSE scores of the CON and AD groups were 23.77 ± 0.327 and 10.88 ± 0.762, respectively. The TYM scores were 44.32 ± 0.389 and 14.37 ± 1.368 in the CON and AD participants, respectively. Findings in the MMSE test were: AUC = 0.962, optimal cut-off score = 18.5, sensitivity = 0.90 and specificity = 0.96. Values in the TYM test were: AUC = 0.991, optimal cut-off score = 31, sensitivity = 0.90 and specificity = 1. We found no correlation between the cognitive performance and age in the CON group but a positive correlation in the AD patients. On the other hand, t-test analysis indicated that achievement of the test scores are significantly sex dependent, with more scores attained by the females. Taken together, in regard to correct classification rate (CCR); the TYM test seems to be more appropriate for cognitive screening in our study. However, considering an analogous AUC, both tests are comparable and have high sensitivity and specificity for discriminating between people with and without AD.

Entities:  

Keywords:  Alzheimer’s disease; MMSE; TYM; dementia

Mesh:

Year:  2019        PMID: 30884962     DOI: 10.1080/13607863.2019.1584786

Source DB:  PubMed          Journal:  Aging Ment Health        ISSN: 1360-7863            Impact factor:   3.658


  3 in total

Review 1.  Alzheimer's disease treatment: The share of herbal medicines.

Authors:  Masoud Soheili; Mohammad Karimian; Gholamali Hamidi; Mahmoud Salami
Journal:  Iran J Basic Med Sci       Date:  2021-02       Impact factor: 2.699

2.  A systematic review and meta-analysis of studies on screening for mild cognitive impairment in primary healthcare.

Authors:  Leila Karimi; Alireza Mahboub-Ahari; Leila Jahangiry; Homayoun Sadeghi-Bazargani; Mostafa Farahbakhsh
Journal:  BMC Psychiatry       Date:  2022-02-09       Impact factor: 3.630

Review 3.  Test Your Memory (TYM) and Test Your Memory for Mild Cognitive Impairment (TYM-MCI): A Review and Update Including Results of Using the TYM Test in a General Neurology Clinic and Using a Telephone Version of the TYM Test.

Authors:  Jeremy M Brown; Julie Wiggins; Kate Dawson; Timothy Rittman; James B Rowe
Journal:  Diagnostics (Basel)       Date:  2019-09-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.